TAK-715

SKU: orb1301032

Description

TAK-715 is a selective small molecule inhibitor targeting the p38α MAP kinase. It has been utilized in research to investigate p38α's role in cellular stress responses and inflammation, with applications in both in vitro biochemical assays and in vivo models of inflammatory disease.

Research Area

Metabolism Research, Signal Transduction, Stem Cell & Developmental Biology

Images & Validation

−

Key Properties

−

CAS Number	303162-79-0
MW	399.51
Purity	98.51%
Formula	C₂₄H₂₁N₃OS
SMILES	CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(C)c1
Target	Casein Kinase,p38 MAPK,JNK
Solubility	Ethanol:20 mg/mL (50.06 mM);DMSO:50 mg/mL (125.15 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.01 mM)

Bioactivity

−

Target IC50	p38β:0.20 μM\|p38δ:>10 μM\|p38γ:>10 μM\|p38α:7.1 nM
In Vivo	TAK 715 (10 mg/kg, po) inhibits LPS-induced TNF-alpha production in mice with 87.6% inhibition. TAK 715 has a modest mouse bioavailability of 18.4% and a slightly improved rat bioavailability of 21.1%. TAK 715 has a modest mouse bioavailability of 18.4% and a slightly improved rat bioavailability of 21.1%. TAK 715 results in Cmax of 0.19 μg/mL and AUC(0-24 hours) of 1.16 μg·h/mL in rats. TAK 715 (30 mg/kg, po) significantly reduces the secondary paw volume with 25 % inhibition in a rat adjuvant-induced arthritis (AA) model. Read more...
In Vitro	TAK 715 inhibits LPS-stimulated release of TNF-alpha from THP-1 with IC50 of 48 nM. TAK 715 (10 μM) inhibits Wnt-3a-induced hDvl2 phosphorylation and the hDvl2 shift in U2OS-EFC cells. The amide NH of TAK 715 is hydrogen bonded to the main-chain carbonyl of Met109 of p38 alpha. TAK 715 binds relatively high in the ATP pocket, occupying the hydrophobic back pocket, the adenine region and the front pocket of p38 as well as extending to most of the length of the Gly-rich loop. Read more...

Storage & Handling

−

Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

TAK 715, TAK1, TAK715, TAK-715, Snai1, Wnt/β-catenin, TNF-α, p38α, p38MAPK, p38δ, p38β, p38γ, p38 MAPK, orally, inhibit, JNK1, ERK1, IKKβ, MEKK1, hDvl2, Inhibitor, CYP3A4, CTGF, arthritis, CaseinKinase, Casein Kinase

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID

9952773 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols

TAK-715 (orb1301032)

Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

No reviews yet

Purity:	>98% (HPLC)
CAS Number:	303162-79-0
MW:	399.508
Formula:	C₂₄H₂₁N₃OS

TAK-715

Description

Research Area

Images & Validation

Key Properties

Bioactivity

Storage & Handling

Alternative Names

Similar Products

TAK-715 [orb1225375]

Quality Guarantee

Compound Identifiers

Key Properties

Documents Download

Request a Document

Protocol Information

TAK-715 (orb1301032)

Step 1: Enter information below

Step 2: Enter the in vivo formulation

Available Sizes

Email

UK Office

US Office

CN Office

Distributors